c-Met is a novel tumor associated antigen for T-cell based immunotherapy against NK/T cell lymphoma
出版年份 2015 全文链接
标题
c-Met is a novel tumor associated antigen for T-cell based immunotherapy against NK/T cell lymphoma
作者
关键词
-
出版物
OncoImmunology
Volume 4, Issue 2, Pages e976077
出版商
Informa UK Limited
发表日期
2015-03-07
DOI
10.4161/2162402x.2014.976077
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Induction of tumor-reactive T helper responses by a posttranslational modified epitope from tumor protein p53
- (2014) Takumi Kumai et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Tumor-derived TGF-β and prostaglandin E2 attenuate anti-tumor immune responses in head and neck squamous cell carcinoma treated with EGFR inhibitor
- (2014) Takumi Kumai et al. Journal of Translational Medicine
- The HSP90 Inhibitor Ganetespib Synergizes with the MET Kinase Inhibitor Crizotinib in both Crizotinib-Sensitive and -Resistant MET-Driven Tumor Models
- (2013) N. Miyajima et al. CANCER RESEARCH
- Effective Anti-Neu-Initiated Antitumor Responses Require the Complex Role of CD4+ T Cells
- (2013) E. D. Mortenson et al. CLINICAL CANCER RESEARCH
- Targeting Epithelial-to-Mesenchymal Transition with Met Inhibitors Reverts Chemoresistance in Small Cell Lung Cancer
- (2013) I. Canadas et al. CLINICAL CANCER RESEARCH
- Oncology Meets Immunology: The Cancer-Immunity Cycle
- (2013) Daniel S. Chen et al. IMMUNITY
- A phase II trial of a selective c-Met inhibitor tivantinib (ARQ 197) monotherapy as a second- or third-line therapy in the patients with metastatic gastric cancer
- (2013) Yoon-Koo Kang et al. INVESTIGATIONAL NEW DRUGS
- Heat Shock Protein 90 Inhibitors Repress Latent Membrane Protein 1 (LMP1) Expression and Proliferation of Epstein-Barr Virus-Positive Natural Killer Cell Lymphoma
- (2013) Takayuki Murata et al. PLoS One
- Limited Induction of Tumor Cross-Reactive T Cells without a Measurable Clinical Benefit in Early Melanoma Patients Vaccinated with Human Leukocyte Antigen Class I-Modified Peptides
- (2012) P. Filipazzi et al. CLINICAL CANCER RESEARCH
- Impact of Tumor Microenvironment and Epithelial Phenotypes on Metabolism in Breast Cancer
- (2012) H. A. Brauer et al. CLINICAL CANCER RESEARCH
- Targeting the Hepatocyte Growth Factor–cMET Axis in Cancer Therapy
- (2012) George R. Blumenschein et al. JOURNAL OF CLINICAL ONCOLOGY
- Antitumor activities of valproic acid on Epstein-Barr virus-associated T and natural killer lymphoma cells
- (2011) Seiko Iwata et al. CANCER SCIENCE
- Phase II Study of SMILE Chemotherapy for Newly Diagnosed Stage IV, Relapsed, or Refractory Extranodal Natural Killer (NK)/T-Cell Lymphoma, Nasal Type: The NK-Cell Tumor Study Group Study
- (2011) Motoko Yamaguchi et al. JOURNAL OF CLINICAL ONCOLOGY
- Six-transmembrane epithelial antigen of the prostate and enhancer of zeste homolog 2 as immunotherapeutic targets for lung cancer
- (2011) Satoshi Hayashi et al. Journal of Translational Medicine
- The Role of Autophagy in Cancer: Therapeutic Implications
- (2011) Z. J. Yang et al. MOLECULAR CANCER THERAPEUTICS
- HGF and c-Met Participate in Paracrine Tumorigenic Pathways in Head and Neck Squamous Cell Cancer
- (2009) L. M. Knowles et al. CLINICAL CANCER RESEARCH
- Heat shock proteins and immune system
- (2009) Min-Fu Tsan et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Efficient Cross-presentation Depends on Autophagy in Tumor Cells
- (2008) Y. Li et al. CANCER RESEARCH
- Combined Clinical Trial Results of a HER2/neu (E75) Vaccine for the Prevention of Recurrence in High-Risk Breast Cancer Patients: U.S. Military Cancer Institute Clinical Trials Group Study I-01 and I-02
- (2008) G. E. Peoples et al. CLINICAL CANCER RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started